🔍 Observations
Topline
- FY26 revenue grew 2.6% YoY (₹36,424M → ₹37,387M) — modest, indicating demand stabilisation rather than acceleration; Q4FY26 added ₹10,365M vs ₹10,180M in Q4FY25, a 1.8% quarterly comp.
- Sequential Q4 bounce of 13% (₹9,171M → ₹10,365M) signals some seasonality recovery after a soft Q3.
- Revenue growth materially trails cost growth — total expenses rose 7.6% YoY vs revenue’s 2.6%, squeezing every margin line.
Bottomline
- FY26 PAT collapsed 36.2% YoY (₹4,962M → ₹3,167M), driven by cost inflation, a ₹766M net exceptional loss, and a ₹590M forex drag vs near-neutral ₹19M in FY25.
- Excluding exceptionals, PBT fell 22.4% (₹6,279M → ₹4,875M) — underlying operations deteriorated significantly, not just optics.
- Q4FY26 PAT at ₹1,479M vs ₹1,833M in Q4FY25 (-19.3%) confirms the weakness persists into year-end.
Margins
- EBITDA proxy (PBT before exceptionals + D&A + Finance costs): FY26 = ₹4,875 + ₹4,529 + ₹488 = ₹9,892M; FY25 = ₹6,279 + ₹4,326 + ₹531 = ₹11,136M. EBITDA margin: FY26 = 26.5% vs FY25 = 30.6% — a 410 bps contraction.
- Net profit margin: FY26 = 8.5% (₹3,167M ÷ ₹37,387M) vs FY25 = 13.6% (₹4,962M ÷ ₹36,424M) — 510 bps erosion.
- Employee costs surged 12.3% YoY (₹9,839M → ₹11,049M), now representing 29.6% of revenue vs 27.0% in FY25 — the single largest margin headwind.
Growth Trajectory
- Two-year revenue trajectory is nearly flat: FY25 grew off a likely stronger FY24 base; FY26 adds only ₹963M incremental — structural growth slowdown is apparent.
- EPS declined 36.3% YoY (₹12.35 → ₹7.87), compressing shareholder returns sharply and raising questions about near-term re-rating potential.
- Capex is decelerating — PP&E purchases dropped from ₹7,603M (FY25) to ₹3,440M (FY26), suggesting the investment cycle is maturing; growth acceleration from new capacity depends on utilisation ramp.
🧮 Profit & Loss Statement
🧮 Balance Sheet
🧮 Cash Flows Statement
🟢 Green Flags
- Debt-light balance sheet: Short-term borrowings slashed from ₹1,196M to ₹94M — near debt-free position de-risks the balance sheet substantially.
- Capex moderation: PP&E spend halved to ₹3,440M, directly boosting free cash flow headroom after a heavy investment cycle.
- Solid OCF despite profit decline: Operating cash flow of ₹9,152M, though lower YoY, still demonstrates strong cash conversion from a high D&A base (₹4,529M non-cash add-back).
- Trade payables improvement: Total payables declined from ₹3,520M to ₹3,475M — no signs of stretched supplier credit being used to mask cash stress.
- Liquid asset base: Cash + bank balances + current investments = ₹2,286M + ₹6,044M + ₹4,561M = ₹12,891M — robust liquidity cushion.
- Q4 sequential recovery: Revenue jumped 13% QoQ and PAT surged ~886% QoQ (₹150M → ₹1,479M) — Q3’s exceptional drag was non-recurring, and operational momentum is recovering.
- Equity base stable: Total equity grew from ₹47,268M to ₹48,391M despite weaker profitability — no equity dilution or balance sheet stress.
🔴 Red Flags
- 36% PAT decline: Even stripping exceptionals, underlying PBT fell 22.4% — this is a genuine operational deterioration, not purely accounting noise.
- Forex drag escalating: Net forex loss jumped from ₹19M to ₹609M — a ₹590M swing that is partly structural given USD-denominated revenues; hedging effectiveness has weakened materially.
- Employee cost inflation unabated: ₹1,210M YoY increase in employee expense with only ₹963M revenue growth — the business is adding cost faster than it’s adding revenue.
- Exceptional losses now recurring: ₹766M net exceptional loss in FY26 vs ₹320M gain in FY25 — two consecutive years of large exceptional items signals operational or strategic instability.
- OCF deterioration: Operating cash flow fell from ₹11,676M to ₹9,152M (-21.6%) — even the cash-generative advantage is narrowing.
- Other current liabilities elevated: ₹7,783M (vs ₹7,196M) — a material deferred income / advance pile that needs monitoring for revenue recognition timing.
- Derivative liabilities spike: Current derivative liabilities surged from ₹56M to ₹1,145M — significant MTM losses on hedging book, adding P&L and balance sheet volatility risk.
📊 Balance Sheet Analysis
- Asset quality is sound: PP&E + CWIP = ₹35,858M, representing 50.8% of total assets — predominantly productive hard assets; CWIP declining (₹12,614M → ₹10,404M) confirms capex cycle peaking.
- Liquidity is strong: Current ratio = ₹21,428M ÷ ₹15,523M = 1.38x; liquid assets alone (₹12,891M) cover all short-term borrowings (₹94M) many times over.
- Leverage is minimal: Total debt (borrowings only) = ₹94M + ₹0M long-term = negligible; debt-to-equity effectively zero, giving significant financial flexibility.
- Derivatives distorting picture: ₹1,145M current derivative liability vs ₹69M asset — net ₹1,076M liability signals aggressive or poorly timed hedges that could crystallise further losses.
💰 Cash Flow Analysis
- FCF improved sharply: OCF ₹9,152M minus capex ₹3,440M = FCF of ₹5,712M vs FY25 FCF of ₹11,676M – ₹7,603M = ₹4,073M — capex discipline is translating into meaningfully better free cash generation.
- Investing outflows reflect treasury activity: Net bank/ICD investment of ₹5,883M (deployed ₹13,828M, redeemed ₹7,945M) — the company is parking surplus cash in safe instruments, not making large strategic bets.
- Financing is clean: Debt repaid, dividend of ₹504M paid, minimal equity issuance — no financial engineering; capital returned to shareholders without balance sheet stress.
- Cash balance declined by ₹1,385M (₹3,671M → ₹2,286M), but total liquid reserves (including bank deposits and mutual funds) actually grew — headline cash drop is misleading.
💡 Investment Outlook
Syngene’s FY26 results reflect a business managing through a margin reset — revenue growth is anemic at 2.6%, profit fell 36%, and forex/employee costs have structurally pressured margins by 400–500 bps.
The strong FCF improvement (₹5,712M vs ₹4,073M) and near-zero debt provide genuine balance sheet comfort, and the Q4 sequential recovery suggests the worst of exceptional charges may be behind.
However, until employee cost growth is brought below revenue growth and the forex hedging book is restructured, earnings recovery will remain gradual.
Investors should monitor Q1FY27 margins closely — sustained EBITDA margin recovery above 28% would be the key re-rating trigger.
Disclaimer: This post features ChartAlert-AI-generated financial content which may contain inaccuracies or errors. This commentary is strictly for informational purposes and does not constitute a recommendation to buy or sell any security. Investors are responsible for performing their own due diligence; always consult with a licensed financial advisor before making investment decisions.
Beyond the Price Action: Fundamental Analysis is Coming to ChartAlert
ChartAlert is evolving into integrated research with a future update that will embed fundamental data into your workflow. Alongside technical analysis, the new release will allow access to financial spreadsheets, quarterly results review, earnings call transcripts, and valuation tools, connecting price action with corporate performance for smarter, data‑driven decisions.